SAREPTA THERAPEUTICS, INC. Increase (Decrease) in Accrued Liabilities
SAREPTA THERAPEUTICS, INC. (SRPT) reported Increase (Decrease) in Accrued Liabilities of -$37.33 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccruedLiabilities · last filed 2026-08-05
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-06-30 was $22.70M.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2026-03-31 was -$60.03M, a 289.64% decline year-over-year.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-06-30 was -$11.49M.
- SAREPTA THERAPEUTICS, INC. increase (decrease) in accrued liabilities for the quarter ending 2025-03-31 was $31.65M.
| Period end | Increase (Decrease) in Accrued Liabilities 3 month | Increase (Decrease) in Accrued Liabilities 6 month |
|---|---|---|
| 2026-06-30 | $22.70M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | -$37.33M 10-Q · filed 2026-08-05 |
| 2026-03-31 | -$60.03M 10-Q · filed 2026-05-06 | |
| 2025-06-30 | -$11.49M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $20.16M 10-Q · filed 2026-08-05 |
| 2025-03-31 | $31.65M 10-Q · filed 2026-05-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Zymeworks Inc. (ZYME) | United States | $1.902B | -12.44 |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| NEKTAR THERAPEUTICS (NKTR) | United States | $2.026B | -9.05 |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| COMPASS Pathways plc (CMPS) | $1.812B | -4.87 | |
| ANI PHARMACEUTICALS INC (ANIP) | United States | $1.810B | 18.77 |